Forge Biologics to Manufacture PRF’s SamPro-2 Gene Therapy for IND Advancement

The Progeria Research Foundation (“PRF”), a nonprofit research organization dedicated to developing treatments and the cure for Hutchinson-Gi...

March 05, 2026 | Thursday | News
Ono and Congruence Deepen Strategic Discovery Alliance Beyond Oncology

Beginning a new drug discovery collaboration using Congruence’s globally recognized Revenir™ platform for the creation of small molecule ...

March 04, 2026 | Wednesday | News
Morcamilast Earns EU Orphan Drug Designation for Rare Inflammatory Skin Disease

Meiji Seika Pharma Co., Ltd. announced that morcamilast (proposed international nonproprietary name; development code: ME3183), a selective phosphodieste...

March 04, 2026 | Wednesday | News
Antengene Corporation Limited Secures South Korea NHIS Reimbursement for XPOVIO® in Multiple Myeloma

- XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea's National Health Insurance Service (NHIS) for the treatment of adult...

March 03, 2026 | Tuesday | News
SciBase Holding AB Secures FDA Label Expansion to Broaden Clinical Use of Nevisense in U.S. Dermatology Practices

SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, announced that it has received appro...

March 03, 2026 | Tuesday | News
Aardvark Therapeutics Voluntarily Pauses Phase 3 HERO Trial of ARD-101 in Prader-Willi Syndrome

Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutic...

March 02, 2026 | Monday | News
Mahzi Doses First Patient in Phase 1/2 Trial of MZ-1866, the First Investigational Gene Therapy for Pitt Hopkins Syndrome

First Investigational Gene Therapy for Pitt Hopkins Syndrome Intended to Address Underlying Disease Biology -- Mahzi Therapeutics Inc., a clinical...

February 27, 2026 | Friday | News
Johnson & Johnson Files for FDA Approval of IMAAVY® in Warm Autoimmune Hemolytic Anemia

Johnson & Johnson announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA), see...

March 26, 2026 | Thursday | News
Antengene and Junshi Biosciences Advance ‘Triple-Axis’ Immunotherapy Strategy in Solid Tumors

Antengene Corporation Limited  ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering...

February 26, 2026 | Thursday | News
PacBio and DNAstack Unite to Accelerate Rare Disease Discovery Through Federated HiFi Sequencing

PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies,  announced a collaboration with DNAstack to power the wor...

February 26, 2026 | Thursday | News
Redefining CNS Therapeutics: A Conversation with Joel Latham on Incannex Healthcare’s Clinical Vision

    Under the leadership of Joel Latham, Incannex Healthcare is advancing a differentiated pipeline of cannabinoid- and psychedelic-based thera...

March 02, 2026 | Monday | Interaction
Altesa BioSciences Raises $75 Million Series B Led by Forbion to Advance First-in-Class Rhinovirus Therapy Vapendavir into Phase 2b

-Financing led by Forbion, joined by Sanofi and existing investors Medicxi, Pitango, and Atlantic Partners- -Proceeds to advance vapendavir, a first-in-...

February 23, 2026 | Monday | News
Sift Biosciences Raises $3.7M Pre-Seed Round to Advance AI-Driven Peptide Immunotherapy Platform

Pre-Seed Round Co-Led By Freeflow Ventures and Lifespan Vision Ventures With Participation From Valuence Ventures, Eisai Innovation, SBI US Gateway Fun...

February 20, 2026 | Friday | News
Hana Health by DSS Imagetech Partners with Overture Life to Introduce Automated Egg-Freezing Technology in India

For the first time in India, couples seeking In Vitro Fertilisation (IVF) treatment for conception can rely on a globally preferred, automated egg-freezi...

February 20, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close